Non-specific interactions of antibody-oligonucleotide conjugates with living cells

被引:0
|
作者
Victor Lehot
Isabelle Kuhn
Marc Nothisen
Stéphane Erb
Sergii Kolodych
Sarah Cianférani
Guilhem Chaubet
Alain Wagner
机构
[1] University of Strasbourg,Bio
[2] University of Strasbourg,Functional Chemistry (UMR 7199), LabEx Medalis
[3] Syndivia SAS,BioOrganicMass Spectrometry Laboratory (LSMBO), IPHC
[4] ISIS,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Antibody-Oligonucleotide Conjugates (AOCs) represent an emerging class of functionalized antibodies that have already been used in a wide variety of applications. While the impact of dye and drug conjugation on antibodies’ ability to bind their target has been extensively studied, little is known about the effect caused by the conjugation of hydrophilic and charged payloads such as oligonucleotides on the functions of an antibody. Previous observations of non-specific interactions of nucleic acids with untargeted cells prompted us to further investigate their impact on AOC binding abilities and cell selectivity. We synthesized a series of single- and double-stranded AOCs, as well as a human serum albumin-oligonucleotide conjugate, and studied their interactions with both targeted and non-targeted living cells using a time-resolved analysis of ligand binding assay. Our results indicate that conjugation of single strand oligonucleotides to proteins induce consistent non-specific interactions with cell surfaces while double strand oligonucleotides have little or no effect, depending on the preparation method.
引用
收藏
相关论文
共 50 条
  • [1] Non-specific interactions of antibody-oligonucleotide conjugates with living cells
    Lehot, Victor
    Kuhn, Isabelle
    Nothisen, Marc
    Erb, Stephane
    Kolodych, Sergii
    Cianferani, Sarah
    Chaubet, Guilhem
    Wagner, Alain
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [2] Antibody-oligonucleotide conjugates enter the clinic
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (01) : 6 - 8
  • [3] Antibody-Oligonucleotide Conjugates: A Twist to Antibody-Drug Conjugates
    Dugal-Tessier, Julien
    Thirumalairajan, Srinath
    Jain, Nareshkumar
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (04) : 1 - 17
  • [4] Antibody-Oligonucleotide Conjugates as Therapeutic, Imaging, and Detection Agents
    Dovgan, Igor
    Koniev, Oleksandr
    Kolodych, Sergii
    Wagner, Alain
    BIOCONJUGATE CHEMISTRY, 2019, 30 (10) : 2483 - 2501
  • [5] An Approach to Multiplexing an Immunosorbent Assay with Antibody-Oligonucleotide Conjugates
    Han, Ki-Cheol
    Ahn, Dae-Ro
    Yang, Eun Gyeong
    BIOCONJUGATE CHEMISTRY, 2010, 21 (12) : 2190 - 2196
  • [6] Non-specific antibody interactions
    Nybo, Kristie
    BIOTECHNIQUES, 2012, 52 (05) : 305 - 306
  • [7] EFFECT OF SPECIFIC ANTIBODY TO TARGET CELLS ON THEIR SPECIFIC AND NON-SPECIFIC INTERACTIONS WITH LYMPHOCYTES
    MACLENNAN, IC
    LOEWI, G
    NATURE, 1968, 219 (5158) : 1069 - +
  • [8] Targeted tissue delivery of RNA therapeutics using antibody-oligonucleotide conjugates (AOCs)
    Malecova, Barbora
    Burke, Rob S.
    Cochran, Michael
    Hood, Michael D.
    Johns, Rachel
    Kovach, Philip R.
    Doppalapudi, Venkata R.
    Erdogan, Gulin
    Arias, J. Danny
    Darimont, Beatrice
    Miller, Christopher D.
    Huang, Hanhua
    Geall, Andrew
    Younis, Husam S.
    Levin, Arthur A.
    NUCLEIC ACIDS RESEARCH, 2023, 51 (12) : 5901 - 5910
  • [9] Structure-Activity Relationship of Antibody-Oligonucleotide Conjugates: Evaluating Bioconjugation Strategies for Antibody-siRNA Conjugates for Drug Development
    Cochran, Michael
    Arias, Danny
    Burke, Rob
    Chu, David
    Erdogan, Gulin
    Hood, Michael
    Kovach, Philip
    Kwon, Hae Won
    Chen, Yanling
    Moon, Michael
    Miller, Christopher D.
    Huang, Hanhua
    Levin, Arthur
    Doppalapudi, Venkata Ramana
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (17) : 14852 - 14867
  • [10] IMPROVED CELLULAR DELIVERY OF ANTISENSE OLIGONUCLEOTIDES USING TRANSFERRIN RECEPTOR ANTIBODY-OLIGONUCLEOTIDE CONJUGATES
    WALKER, I
    IRWIN, WJ
    AKHTAR, S
    PHARMACEUTICAL RESEARCH, 1995, 12 (10) : 1548 - 1553